Lunning Lends Insight on Pivotal Data From Pan Pacific Lymphoma 2022

Season 7 Episode 46  ·  Nov 10, 2022, 07:15 PM
Headliner
Share
Subscribe

In this inaugural episode, Dr Lunning details important findings to come out of the Pan Pacific Lymphoma Conference, including results evaluating prophylactic medications in the management of patients with hematologic malignancies receiving cellular therapy or autologous stem cell transplant.

Share
Subscribe
Next
FDA Approval Insights: Teclistamab in Relapsed/Refractory Multiple Myeloma
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air